Evidence map›Paper›PMID 35010887›Full record

SynthesisNutrients2021

Gut Microbiome Composition in Obese and Non-Obese Persons: A Systematic Review and Meta-Analysis.

Mariona Pinart, Andreas Dötsch, Kristina Schlicht, Matthias Laudes, Jildau Bouwman, Sofia K Forslund, Tobias Pischon, Katharina Nimptsch

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 244 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
244citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

244 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Microbiome Composition in Microscopic Colitis: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  12. Trial
  13. Trial
  14. A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Review

184 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mariona PinartMolecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.ORCID 0000-0002-8223-1325
Andreas DötschDepartment of Physiology and Biochemistry of Nutrition, Max Rubner-Institut (MRI)-Federal Research Institute of Nutrition and Food, 76131 Karlsruhe, Germany.ORCID 0000-0001-9086-2584
Kristina SchlichtInstitute of Diabetes and Clinical Metabolic Research, University of Kiel, 24105 Kiel, Germany.
Matthias LaudesInstitute of Diabetes and Clinical Metabolic Research, University of Kiel, 24105 Kiel, Germany.
Jildau BouwmanMicrobiology and Systems Biology Group, Toegepast Natuurwetenschappelijk Onderzoek (TNO), Utrechtseweg 48, 3704 HE Zeist, The Netherlands.
Sofia K ForslundExperimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Lindenberger Weg 80, 13125 Berlin, Germany.ORCID 0000-0003-4285-6993
Tobias PischonMolecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.ORCID 0000-0003-1568-767X
Katharina NimptschMolecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.

Funding

Federal Ministry of Food and Agriculture 01EA1906B
6 · The paper itself

Abstract

Whether the gut microbiome in obesity is characterized by lower diversity and altered composition at the phylum or genus level may be more accurately investigated using high-throughput sequencing technologies. We conducted a systematic review in PubMed and Embase including 32 cross-sectional studies assessing the gut microbiome composition by high-throughput sequencing in obese and non-obese adults. A significantly lower alpha diversity (Shannon index) in obese versus non-obese adults was observed in nine out of 22 studies, and meta-analysis of seven studies revealed a non-significant mean difference (-0.06, 95% CI -0.24, 0.12,

Indexed as

Gastrointestinal MicrobiomeBacteriaFecesHigh-Throughput Nucleotide SequencingHumansObesity16S sequencingadultBMIgastrointestinal microbiomehumansobesityshotgun metagenomics

Identifiers

PMID35010887
PMCPMC8746372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.